All News
Novel Anticoagulant Flops for Staving Off Graft Thrombosis in Dialysis Patients
(MedPage Today) -- An investigational anticoagulant that targets factor XI failed to prevent arteriovenous graft (AVG) thrombosis in chronic hemodialysis patients, according to a placebo-controlled p
Read MoreAI-Directed Breast MRI Could Lead to Faster Scan Times Without Affecting Accuracy
(MedPage Today) -- Use of an artificial intelligence (AI)-directed tool for breast MRI could reduce scan times without compromising diagnostic performance, a retrospective simulation study suggested.
Read MoreHome Testing Doubles Cervical Cancer Screening in Safety-Net Population
(MedPage Today) -- Participation in a cervical cancer screening program in a safety-net health system more than doubled when patients received at-home test kits by mail rather than just a telephone r
Read MoreInfectious Disease Docs Slam New COVID Vaccine Recommendations
(MedPage Today) -- Infectious disease physicians expressed alarm over how the Trump administration bypassed open and established processes for changing vaccine recommendations, and voiced particular
Read MoreOpinion: STAT+: RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
His admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.
Read MoreSTAT+: As Omada goes public, executives reflect on why profits are elusive in digital health
Omada Health, a digital health company for 14 years supporting chronic disease patients, is yet to generate profits.
Read MoreSome Psych Meds Tied to Higher Future Risk of ALS
(MedPage Today) -- Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of amyotrophic lateral sclerosis (ALS) diagnosis and a poorer pro
Read MoreTribes Question Kennedy’s Promise To Protect Them From Health Cuts
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Read MoreSTAT+: FDA reassures rare disease advocates that ‘being flexible’ is plan for gene therapy
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals.
Read MoreWhy Choose Second Opinions? Risky Cancer Searches; 18 Months to Live, 20 Years Later
(MedPage Today) -- New insights into why patients with cancer choose to go with recommendations from a second opinion rather than the initial advice.
Read More